Patterns of cancer screening in primary care from 2005 to 2010

Cancer

Volumn 120, Issue 2, 2014, Pages 253-261

  Martires, Kathryn J ^a,b   Kurlander, David E ^c   Minwell, Gregory J ^d   Dahms, Eric B ^a   Bordeaux, Jeremy S ^c,e  

^a SCRIPPS MERCY HOSPITAL   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

breast cancer; cancer screening; cervical cancer; melanoma; primary care; prostate cancer; skin cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER SCREENING; CANCER TEST; DIGITAL RECTAL EXAMINATION; FEMALE; HEALTH INSURANCE; HUMAN; MALE; MAMMOGRAPHY; MEDICARE; PAPANICOLAOU TEST; PELVIC EXAMINATION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN TEST; RACE; RACE DIFFERENCE; SKIN CANCER; SKIN EXAMINATION; SMOKING; SOCIAL STATUS; UTERINE CERVIX CANCER;

EID: 84891856809     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28403     Document Type: Article

References (65)

1. Smith RA, Cokkinides V, Brawley OW,. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009; 59: 27-41.
2. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW,. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010; 60: 99-119.
3. American College of Obstetricians-Gynecologists. Practice bulletin no. 122: breast cancer screening. Obstet Gynecol. 2011; 118: 372-382.
4. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 151: 716-726, W236.
5. World Health Organization. Breast Cancer: Prevention and Control. Geneva, Switzerland: World Health Organization; 2013. Available at: http://www.who.int/cancer/detection/breastcancer/en/index.html. Accessed April 12, 2013.
6. US Preventive Services Task Force. Screening for skin cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 150: 188-193.
7. Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS,. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005. J Am Acad Dermatol. 2007; 57: 60-66.
8. Field MJ, Lawrence RL, Zwanziger L, eds; Committee on Medicare Coverage Extensions, Division of Health Care Services, Institute of Medicine. Extending Medicare Coverage for Preventive and Other Services. Washington, DC: National Academy Press; 1991. Available at: http://www.nap.edu/openbook.php?isbn= 0309068894. Accessed April 12, 2013.
9. Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA Guideline. J Urol. 2013; 190: 419-426.
10. Greene KL, Albertsen PC, Babaian RJ, et al. Prostate specific antigen best practice statement: 2009 update. J Urol. 2013; 189: S2-S11.
11. Moyer VA,; US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157: 120-134.
12. Committee on Gynecologic Practice. Committee opinion no. 534: well-woman visit. Obstet Gynecol. 2012; 120: 421-424.
13. Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU,. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2011; 155: 687-697, W214-W215.
14. Moyer VA,; US Preventive Services Task Force. Screening for ovarian cancer: US Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2012; 157: 900-904.
15. National Ambulatory Health Care/National Hospital Ambulatory Medical Care Survey (NAMCS/NHAMCS). About the Ambulatory Health Care Surveys. Available at: http://www.cdc.gov/nchs/ahcd/about-ahcd.htm. Accessed April 30, 2013.
16. National Ambulatory Health Care/National Hospital Ambulatory Medical Care Survey NAMCS/NHAMCS. Questionnaires, Datasets, and Related Documentation. Available at: http://www.cdc.gov/nchs/ahcd/ahcd-questionnaires.htm. Accessed April 30, 2013.
17. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54: 78-93.
18. Simard EP, Fedewa S, Ma J, Siegel R, Jemal A,. Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007. Cancer. 2012; 118: 5110-5116.
19. Patel VB, Nahar R, Murray B, Salner AL,. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut-a secret-shopper survey. Conn Med. 2013; 77: 197-203.
20. Kempe KL, Larson RS, Shetterley S, Wilkinson A,. Breast cancer screening in an insured population: whom are we missing? Perm J. 2013; 17: 38-44.
21. Harper, S., Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC,. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiol Biomarkers Prev. 2009; 18: 121-131.
22. Baquet CR, Commiskey P,. Socioeconomic factors and breast carcinoma in multicultural women. Cancer. 2000; 88: 1256-1264.
23. Wen CP, Tsai SP, Chung W-SI,. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med. 2008; 148: 258-267.
24. Mulligan CR, Meram AD, Proctor CD, Wu H, Zhu K, Marroqi AJ,. Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 25-31.
25. Patel N, Bae S, Singh KP,. Association between utilization of preventive services and health insurance status: findings from the 2008 Behavioral Risk Factor Surveillance System. Ethn Dis. 2010; 20: 142-147.
26. Watts L, Joseph N, Velazquez A, et al. Understanding barriers to cervical cancer screening among Hispanic women. Am J Obstet Gynecol. 2009; 201: 199.e1-199.e8.
27. Erickson BK, Zhang B, Straughn JM Jr,. Screening behaviors and cultural barriers in women with newly diagnosed cervical cancer [published online ahead of print April 16, 2013]. J Low Genit Tract Dis. 2013.
28. Armstrong K, Putt M, Halbert CH, et al. Prior experiences of racial discrimination and racial differences in health care system distrust. Med Care. 2013; 51: 144-150.
29. Clegg LX, Beichman ME, Miller BA, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the Surveillance, Epidemiology, and End Results: National Longitudinal Mortality Study. Cancer Causes Control. 2000; 20: 417-435.
30. Powell IJ,. Prostate cancer and African-American men. Oncology (Williston Park). 1997; 11: 599-605; discussion 606-615 passim.
31. Martin DN, Starks AM, Ambs S,. Biological determinants of health disparities in prostate cancer. Curr Opin Oncol. 2013; 25: 235-241.
32. Miller JW, King JB, Joseph DA, Richardson LC,; Centers for Disease Control and Prevention (CDC). Breast cancer screening among adult women-Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep. 2013; 61 (suppl): 46-50.
33. Grabowski DC,. Medicare and Medicaid: conflicting incentives for long-term care. Milbank Q. 2007; 85: 579-610.
34. Hsia J, Kemper E, Kiefe C, et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med. 2000; 31: 261-270.
35. Brooks DD, Wolf A, Smith RA, Dash C, Guessous I,. Prostate cancer screening 2010: updated recommendations from the American Cancer Society. J Natl Med Assoc. 2010; 102: 423-442.
36. Wolf AM, Wender RC, Etzioni RB, et al. American Cancer Society Prostate Cancer Advisory Committee. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010; 60: 70-98.
37. Kale MS, Bishop TF, Federman AD, Keyhani S,. Trends in the overuse of ambulatory health care services in the United States. JAMA Intern Med. 2013; 173: 142-148.
38. Miller AB, To T, Baines CJ, Wall C,. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000; 92: 1490-1499.
39. Chiarelli AM, Maipruz V, Brown P, Theriault M, Shumak R, Mai V,. The contribution of clinical breast examination to the accuracy of breast screening. J Natl Cancer Inst. 2009; 101: 1236-1243.
40. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med. 2009; 151: 727-737, W237-W242.
41. Smith RA, Brooks D, Cokkinides V, Saslow D, Brawley OW,. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin. 2013; 63: 88-105.
42. Westhoff CL, Jones HE, Guiahi M,. Do new guidelines and technology make the routine pelvic examination obsolete? J Womens Health (Larchmt). 2011; 20: 5-10.
43. Henderson JT, Harper CC, Gutin S, Saraiya M, Chapman J, Sawaya GF,. Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists. Am J Obstet Gynecol. 2013; 208: 109.e1-109.e17.
44. Domar AD,. Psychological aspects of the pelvic exam: individual needs and physician involvement. Women Health. 1985; 10: 75-90.
45. Simard EP, Ward EM, Siegel R, Jemal A,. Cancers with increasing incidence trends in the United States: 1999 through 2008 [published online ahead of print January 4, 2012]. CA Cancer J Clin. 2012.
46. Little EG, Eide MJ,. Update on the current state of melanoma incidence. Dermatol Clin. 2012; 30: 355-361.
47. Wolff T, Tai E, Miller T,. Screening for Skin Cancer: An Update of the Evidence for the US Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2009. Available at: http://www.ncbi.nlm.nih. gov/books/NBK34051/. Accessed April 30, 2013.
48. Petitti DB, Teutsch SM, Barton MD, et al. Update on the methods of the US Preventive Services Task Force: insufficient evidence. Ann Intern Med. 2009; 150: 199-205.
49. Curiel-Lewandrowski C, Chen SC, Swetter SM,; Melanoma Prevention Working Group-Pigmented Skin Lesion Sub-Committee. Screening and prevention measures for melanoma: is there a survival advantage? Curr Oncol Rep. 2012; 14: 458-467.
50. Oliveria SA, Christos PJ, Marghoob AA, Halpern AC,. Skin cancer screening and prevention in the primary care setting: National Ambulatory Medical Care Survey 1997. J Gen Intern Med. 2001; 16: 297-301.
51. Yarnall KSH, Pollak KI, Ostbye T, Krause KM, Michener JL,. Primary care: is there enough time for prevention? Am J Public Health. 2003; 93: 635-641.
52. Davis K, Haisfield L, Dorfman C, Krist A, Taylor KL,. Physicians' attitudes about shared decision making for prostate cancer screening. Fam Med. 2011; 43: 260-266.
53. Nekhlyudov L, Braddock CH 3rd,. An approach to enhance communication about screening mammography in primary care. J Womens Health (Larchmt). 2009; 18: 1403-1412.
54. Geller AC, O'Riordan DL, Olilveria SA, Valvo S, Teich M, Halpern AC,. Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. J Am Board Fam Pract. 2004; 17: 416-423.
55. Oliveria SA, Heneghan MK, Cushman LF, Ughetta EA, Halpern AC,. Skin cancer screening by dermatologists, family practitioners, and internists: barriers and facilitating factors. Arch Dermatol. 2011; 147: 39-44.
56. Redelmeier DA, Tan SH, Booth GL,. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998; 338: 1516-1520.
57. Office on Smoking and Health, Centers for Disease Control and Prevention (CDC). Surgeon General's Reports on Smoking and Tobacco Use. Atlanta, GA: CDC; 2004. Available at: http://www.cdc.gov/tobacco/data-statistics/sgr/2004/. Accessed April 12, 2013.
58. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL,. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005; 128: 2099-2107.
59. Covey LS, Glassman AH, Stetner F,. Cigarette smoking and major depression. J Addict Dis. 1998; 17: 35-46.
60. Vogt F, Hall S, Marteau TM,. General practitioners' and family physicians' negative beliefs and attitudes towards discussing smoking cessation with patients: a systematic review. Addiction. 2005; 100: 1423-1431.
61. Wood ME, Flynn BS, Stockdale A,. Primary care physician management, referral, and relations with specialists concerning patients at risk for cancer due to family history. Public Health Genomics. 2013; 16: 75-82.
62. Iglehart JK,. Expanding the role of advanced nurse practitioners-risks and rewards. N Engl J Med. 2013; 368: 1935-1941.
63. Donelan K, DesRoches CM, Dittus RS, Buerhaus P,. Perspectives of physicians and nurse practitioners on primary care practice. N Engl J Med. 2013; 368: 1898-1906.
64. Dil MJ, Pankow S, Erikson C, Shipman S,. Survey shows consumers open to a greater role for physician assistants and nurse practitioners. Health Aff (Millwood). 2013; 32: 1135-1142.
65. Allison JE, Potter MB,. New screening guidelines for colorectal cancer: a practical guide for the primary care physician. Prim Care. 2008; 36: 575-602.